Novartis skin drug helps patients with chronic hives

ZURICH (Reuters) - Swiss drugmaker Novartis said its drug omalizumab significantly improved itch in patients with a severe form of hives, according to a late-stage study. The second of three late-stage studies found that more than one third of patients with chronic spontaneous urticaria (CSU) who were treated with the drug were completely itch and hive-free after 12 weeks compared to 5 percent of patients on placebo. Omalizumab, which is also known as Xolair, is already approved for treating severe asthma. ...

via Health News Headlines - Yahoo! News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/06/novartis-skin-drug-helps-patients-with.html